Withholding of Life-sustaining Treatment and Quality of Life After Severe Acute Brain Injury: Qualitative Analysis and Ethical Issues
NCT ID: NCT06523127
Last Updated: 2024-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
14 participants
OBSERVATIONAL
2024-06-03
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There are few studies on withholding treatment compared with withdrawing treatment, and even fewer on survivors after a decision to withhold treatment.
Quality of life is defined by WHO as "an individual's perception of his or her position in life in the context of the culture and value systems in which he or she lives and in relation to his or her goals, expectations, standards and concerns". The relationship between quality of life and neurological outcome after severe acute brain injury is controversial and therefore difficult to predict.
That's why the investigators question the legitimacy of making decisions to withhold treatment from patients with severe acute brain injury based on their expected quality of life, when this prediction is uncertain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Iatrogenic Withdrawal Symptoms in Severe Traumatic Brain Injury
NCT04320927
Multimodal Monitoring Study in Neuro Critical Care
NCT06900101
Predict Severe Traumatic Brain Injury
NCT06966713
Hyperbaric Oxygen Therapy in Chronic Stable Brain Injury
NCT00830453
The Effects of Hyperbaric Oxygen on Non-acute Traumatic Brain Injury
NCT05387018
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with severe acute brain injury and with withholding of life-sustaining treatment
Assessment of quality of life in patients with severe acute brain injury based on the audio recording during post-ICU follow-up.
Recording data from the ICU stay and the post-ICU follow-up.
Record analysis of the post-ICU follow-up with the Interpretative Phenomenological Analysis
Patients with severe acute brain injury and without withholding of life-sustaining treatment
Assessment of quality of life in patients with severe acute brain injury based on the audio recording during post-ICU follow-up.
Recording data from the ICU stay and the post-ICU follow-up.
Record analysis of the post-ICU follow-up with the Interpretative Phenomenological Analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Recording data from the ICU stay and the post-ICU follow-up.
Record analysis of the post-ICU follow-up with the Interpretative Phenomenological Analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with severe acute brain injury (TBI, stroke, central nervous system infection).
* admitted in the neurocritical care unit in 2022.
* followed up 24 months after ICU between 15th April 2024 and 31st August 2024.
Exclusion Criteria
* death in 2024,
* refusal by patient or relative.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie DAKENG, resident
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire de Saint Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRBN672024/CHUSTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.